Poor diet quality and food diversity was associated with higher risk for severe symptoms in patients with IBS.

For patients with obesity and type 2 diabetes, dapagliflozin plus calorie restriction associated with high rate of remission of diabetes.

On a global scale, childhood maltreatment is associated with a higher risk for developing some immune-mediated inflammatory disorders.